LFTD Partners (LIFD) 10-Q 13 Nov 15 2015 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2015	Nov. 12, 2015
Document and Entity Information:
Entity Registrant Name	ACQUIRED SALES CORP
Document Type	10-Q
Document Period End Date	Sep. 30, 2015
Amendment Flag	false
Entity Central Index Key	1,391,135
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		2,269,648
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q3
Trading Symbol	aqsp

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($)	Sep. 30, 2015	Dec. 31, 2014
Current Assets
Cash and cash equivalents	$ 84,322	$ 587,937
Prepaid expenses		7,985
Total Current Assets	84,322	595,922
Note receivable		602,500
Interest receivable		35,926
Total Assets	84,322	1,234,348
Current Liabilities
Trade accounts payable	12,646	24,982
Total Liabilities	$ 12,646	$ 24,982
Shareholders' Equity
Preferred stock, $0.001 par value; 10,000,000 shares authorized; none outstanding
Common stock, $0.001 par value; 100,000,000 shares authorized; 2,269,648 shares outstanding	$ 2,270	$ 2,270
Additional paid-in capital	13,554,524	13,554,524
Accumulated deficit	(13,485,118)	(12,347,428)
Total Shareholders' Equity	71,676	1,209,366
Total Liabilities and Shareholders' Equity	$ 84,322	$ 1,234,348

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2015	Dec. 31, 2014
Statement of Financial Position
Common Stock, par or stated value	$ 0.001	$ 0.001
Common Stock, shares authorized	100,000,000	100,000,000
Common Stock, shares outstanding	2,269,648	2,269,648
Preferred Stock, par or stated value	$ 0.001	$ 0.001
Preferred Stock, shares authorized	10,000,000	10,000,000
Preferred Stock, shares issued
Preferred Stock, shares outstanding

CONDENSED STATEMENTS OF OPERATI

CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Income Statement
Selling, General and Administrative Expense	$ (52,944)	$ (103,591)	$ (366,181)	$ (251,169)
Bad Debt Expense	(835,277)		(835,277)
Interest Income	17,726	16,094	61,501	16,094
Other Income		4,534	2,267	20,797
Loss from Continuing Operations	(870,495)	(82,963)	(1,137,690)	(214,278)
Gain (Loss) on Disposal of Discontinued Operations		74,605		74,605
Net Income (Loss)	$ (870,495)	$ (8,358)	$ (1,137,690)	$ (139,673)
Basic and Diluted Earnings (Loss) per Share
Continuing Operations	$ (0.38)	$ (0.04)	$ (0.50)	$ (0.09)
Discontinued Operations	0	0.03	0	0.03
Net Income ( Loss) per Share	$ (0.38)	$ (0.01)	$ (0.50)	$ (0.06)

CONDENSED STATEMENTS OF SHAREHO

CONDENSED STATEMENTS OF SHAREHOLDERS' EQUITY (DEFICIT) - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Stockholders' Equity beginning of period, Value at Dec. 31, 2013	$ 2,270	$ 8,410,295	$ (7,026,157)	$ 1,386,408
Stockholders' Equity beginning of period, Shares at Dec. 31, 2013	2,269,648
Net Income (Loss)			(139,673)	(139,673)
Stockholders' Equity, end of period, Value at Sep. 30, 2014	$ 2,270		(7,165,830)	1,246,735
Stockholders' Equity, end of period, Shares at Sep. 30, 2014	2,269,648
Stockholders' Equity beginning of period, Value at Dec. 31, 2014	$ 2,270	13,554,524	(12,347,428)	1,209,366
Stockholders' Equity beginning of period, Shares at Dec. 31, 2014	2,269,648
Net Income (Loss)			(1,137,690)	(1,137,690)
Stockholders' Equity, end of period, Value at Sep. 30, 2015	$ 2,270	$ 13,554,524	$ (13,485,118)	$ 71,676
Stockholders' Equity, end of period, Shares at Sep. 30, 2015	2,269,648

CONDENSED STATEMENTS OF CASH FL

CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Cash Flows from Operating Activities
Net Income (Loss)	$ (1,137,690)	$ (139,673)
Adjustments to reconcile income (loss) to net cash used in operating activities:
Bad debt expense	835,277
Income from discontinued operations		(74,605)
Changes in operating assets and liabilities:
Prepaid expenses	7,985	(7,985)
Accrued interest receivable	(61,501)	(16,094)
Accounts payable	(12,336)	37,045
Net cash used in operating activities of continuing operations	(368,265)	(201,312)
Net cash provided by (used in) operating activities of discontinued operations		74,605
Net cash used in operating activities	(368,265)	(126,707)
Cash Flows from Investing Activities
Proceeds from sale of discontinued operations, net of cash sold		1,000,000
Note Receivable	(135,350)	(602,500)
Net cash provided by investing activities	(135,350)	397,500
Cash Flow from Financing Activities
Proceeds from borrowing under related party note payable		300,000
Payment of principle on related party note payable		(300,000)
Payment of obligation under stock repurchase		(20,000)
Net cash used in financing activities		(20,000)
Net Increase (Decrease) in Cash	(503,615)	250,793
Cash and Cash Equivalents at Beginning of Period	587,937	427,294
Cash and Cash Equivalents at End of Period	$ 84,322	$ 678,087
Supplemental Cash Flow Information
Cash paid for interest
Cash paid for income taxes		$ 822

Note 1 - Basis of Presentation

Note 1 - Basis of Presentation and Significant Accounting Policies	9 Months Ended
	Sep. 30, 2015
Notes
Note 1 - Basis of Presentation and Significant Accounting Policies	NOTE 1 – BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation – On January 12, 2013, Acquired Sales entered into an agreement with Drumright Group, LLC (“Drumright”) that was closed on February 11, 2013, wherein Acquired Sales sold 100% of the capital stock of Cogility Software Corporation (“Cogility”) to Drumright. Cogility’s results of operations have been reclassified as discontinued operations. Condensed Financial Statements Use of Estimates Basic and Diluted Earnings (Loss) Per Common Share For the Three Months For the Nine Months Ended Ended September 30, September 30, 2015 2014 2015 2014 Loss from Continuing Operations $(870,495) $(82,963) $(1,137,690) $(214,278) Income (Loss) from Discontinued Operations - 74,605 - 74,605 Net Lncome (Loss) $(870,495) $(8,358) $(1,137,690) $(139,673) Weighted -Average Shares Outstanding 2,269,648 2,269,648 2,269,648 2,269,648 Basic and Diluted Earnings (Loss) per Share Continuing Operations $(0.38) $(0.04) $(0.50) $(0.09) Discontinued Operations - 0.03 - 0.03 Basic and Diluted Earnings (Loss) per Share $(0.38) $(0.01) $(0.50) $(0.06) There were 4,848,774 employee stock options and 938,000 warrants outstanding during the three and nine months ended September 30, 2015 that were excluded from the computation of diluted earnings (loss) per share because their effects would have been anti-dilutive. There were 2,148,774 employee stock options and 938,000 warrants outstanding during the three and nine months ended September 30, 2014 that were excluded from the computation of diluted earnings (loss) per share because their effects would have been anti-dilutive. Recent Accounting Pronouncements In June 2014, the FASB issued ASU No. 2014-12, Compensation-Stock Compensation (Topic 718)-Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period (a consensus of the FASB Emerging Issues Task Force). ASU No. 2014-12 requires that a performance target that affects vesting and could be achieved after the requisite service period shall be treated as a performance condition. The effective date will be the first quarter of fiscal year 2016. The Company has not determined the potential effects on the financial statements.

Note 2 - Risks and Uncertaintie

Note 2 - Risks and Uncertainties	9 Months Ended
	Sep. 30, 2015
Notes
Note 2 - Risks and Uncertainties	NOTE 2 - RISKS AND UNCERTAINTIES Going Concern – The sale of Cogility and DSTG eliminated the Company’s source of revenue. As a result, there is substantial doubt that the Company will be able to continue as a going concern. Bankruptcy of the Company at some point in the future is a possibility. The accompanying financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. Management plans to sustain the Company as a going concern by taking the following actions: (1) acquiring and/or developing profitable businesses that will create positive income from operations; (2) acquiring valuable real estate in exchange for common stock and/or preferred stock; and/or (3) completing private placements of our common stock and/or preferred stock. Management believes that by taking these actions, the Company will be provided with sufficient future operations and cash flow to continue as a going concern. However, there can be no assurance that the Company will be successful in consummating such actions on acceptable terms, if at all. Moreover, any such actions can be expected to result in substantial dilution to the existing shareholders of the Company.

Note 3 - The William Noyes Webs

Note 3 - The William Noyes Webster Foundation, Inc.	9 Months Ended
	Sep. 30, 2015
Notes
Note 3 - The William Noyes Webster Foundation, Inc.	NOTE 3 – THE WILLIAM NOYES WEBSTER FOUNDATION, INC. The William Noyes Webster Foundation, Inc. (the "Foundation"), a non-profit Massachusetts corporation, received a provisional registration from the Commonwealth of Massachusetts to own and operate a medical marijuana cultivation facility in Plymouth, Massachusetts (the “Plymouth Cultivation Facility”), and a medical marijuana dispensary in Dennis, Massachusetts (the “Dennis Dispensary”). Jane W. Heatley ("Heatley") is the founder and a member of the board of directors of the Foundation. Teaming Agreement – Promissory Note Between April and July 2015, AQSP loaned an additional $135,350 to the Foundation, evidenced by the Note and secured by the Security Agreement. Following such additional loans, the principal of the loan from AQSP to the Foundation, evidenced by the Note and secured by the Security Agreement, is now $737,850. The principal balance outstanding under the Note bore interest at the rate of 12.5% per annum, compounded monthly. It was contemplated that the first payment of accrued interest by the Foundation under the Note would be made as soon after the Foundation commences operations of the Plymouth Cultivation Facility and the Dennis Dispensary as the Foundation's cash flows shall reasonably permit, but in any event no later than one year after the Foundation commences operations. The principal of the Note would be payable in eight consecutive equal quarterly installments, commencing on the last day of the calendar quarter in which the Foundation commences operations. Principal on the Note and related accrued interest would be considered past due if the aforementioned payments were not received by their due dates. Uncollectable Note and Interest Receivable –

Note 4 - Notes Payable

Note 4 - Notes Payable	9 Months Ended
	Sep. 30, 2015
Notes
Note 4 - Notes Payable	NOTE 4 – NOTES PAYABLE Notes Payable to Related Parties

Note 5 - Shareholders' Equity

Note 5 - Shareholders' Equity	9 Months Ended
	Sep. 30, 2015
Notes
Note 5 - Shareholders' Equity	NOTE 5 – SHAREHOLDERS’ EQUITY Share-Based Compensation Weighted-Average Aggregate Weighted-Average Remaining Contractual Intrinsic Shares Exercise Price (a) Term (Years) Value Outstanding, December 31, 2014 6,198,774 $1.56 Terminated warrants (1,350,000) Outstanding, September 30, 2015 4,848,774 $1.56 7.39 $2,125,125 Exercisable, September 30, 2015 3,598,774 $1.46 6.05 $2,125,125 Note: (a) On July 20, 2015, the Board of Directors of AQSP agreed and acknowledged that all of the rights to purchase warrants, granted to members of the board of directors of AQSP, whose exercise price was based on the planned capital raise to fund the proposed acquisition of PPV, Inc. are now terminated. As a result of this termination, rights to purchase warrants, granted to members of the board of directors of AQSP, exercisable into 1,350,000 shares of AQSP have been terminated. Financing Warrants Common Stock

Note 6 - Contingent Contractual

Note 6 - Contingent Contractual Obligations and Commercial Commitments	9 Months Ended
	Sep. 30, 2015
Notes
Note 6 - Contingent Contractual Obligations and Commercial Commitments	NOTE 6 – CONTINGENT CONTRACTUAL OBLIGATIONS AND COMMERCIAL COMMITMENTS Medical Marijuana in Massachusetts: As discussed in Note 3, the Company has agreements with Heatley and the William Noyes Webster Foundation, Inc. (the “Foundation”). AQSP has agreed to pay a lump sum finder's fee to Parare Partners Inc. in the event that all of the following conditions occur: (1) AQSP makes certain loans to the William Noyes Webster Foundation, Inc. (the "Foundation") which was found by Parare Partners Inc., (2) the Foundation constructs and brings into operation its planned medical marijuana cultivation facility in Plymouth, Massachusetts (the “Plymouth Cultivation Facility”) and medical marijuana dispensary in Dennis, Massachusetts (the “Dennis Dispensary”), (3) AQSP directly or via subsidiaries enters into certain consulting agreements with the Foundation, and (4) all necessary approvals are obtained. If all of such conditions occur, then the finder's fee will be calculated as follows: (i) 5% of the first $1,000,000 of the aggregate principal amount of such loans, (ii) 4% of the second $1,000,000 of the aggregate principal amount of such loans, (iii) 3% of the third $1,000,000 of the aggregate principal amount of such loans, (iv) 2% of the fourth $1,000,000 of the aggregate principal amount of such loans, and (v) 1% of the aggregate principal amount of such loans that are in excess of $4,000,000. As of September 30, 2015, no finder’s fees are due to Parare Partners, Inc. During the nine month period ended September 30, 2015, MVJ Realty, LLC, an affiliate of AQSP director Vincent J. Mesolella (“MVJ Realty”), loaned a total of $23,000 to the Foundation, which $23,000 was used as follows: (a) $9,500 was used by the Foundation to pay the rent of the Plymouth Cultivation Facility for the month of May, 2015; (b) $6,900 was used by the Foundation to pay the rent of the Dennis Dispensary for the months of April and May, 2015; (c) $3,600 was used by the Foundation to pay for the general liability insurance policy covering the Plymouth Cultivation Facility and the Dennis Dispensary; and (d) $3,000 was used by the Foundation to pay the application fees for two applications (the “Two New Applications”) by the Foundation to the Commonwealth of Massachusetts for licenses (the “Two New Licenses”) to operate two new medical marijuana dispensaries in Massachusetts (the “Two New Dispensaries”). In making these $23,000 loans to the Foundation, MVJ Realty viewed itself as acting as an agent for AQSP, and expected to eventually be reimbursed for the $23,000 by AQSP subject to the execution and delivery by the Foundation to AQSP of loan documents evidencing that the principal amount of the loan from AQSP to the Foundation, evidenced by the Note and secured by the Security Agreement, had been increased by $23,000. The execution and delivery of such loan documents occurred on July 15, 2015, and MVJ Realty was reimbursed for the $23,000 in August 2015. In the Two New Applications, the Foundation included background information in regard to each director and officer of AQSP. If the Two New Licenses are awarded to the Foundation, then the Foundation may seek to obtain financing for the Two New Dispensaries from MVJ Realty/AQSP. The Foundation and MVJ Realty/AQSP have not yet entered into any agreements in regard to such potential financing, and AQSP considers it to be extremely doubtful that any such agreements will ever be entered into in light of the on-going disputes between AQSP, Heatley and the Foundation regarding the Teaming Agreement. At this time, no assurances or guarantees whatsoever can be made as to whether any transaction with the Foundation will be successfully consummated, nor on what terms. Acquisition of Real Estate As discussed in AQSP’s prior public filings, AQSP and one of its directors, Vincent J. Mesolella, have agreed to negotiate in good faith regarding the possibility of AQSP acquiring certain parcels of real estate in Rhode Island that are owned by entities affiliated with Vincent J. Mesolella and his son Derek V. Mesolella, an independent contractor to AQSP, one of which parcels is also partly owned by an affiliate of AQSP’s chief executive officer, Gerard M. Jacobs (collectively, the “Mesolella/Jacobs Properties”). The independent members of the board of directors of AQSP, Joshua A. Bloom, Michael D. McCaffrey and Richard E. Morrissy, met separately and decided to cause AQSP to retain an MAI appraiser in Rhode Island to appraise the Mesolella/Jacobs Properties and one other parcel of real estate in Rhode Island that is owned by an unrelated third party (the “Unrelated Parcel”) who expressed a potential interest in AQSP acquiring the Unrelated Parcel. The parties have been unable to agree upon mutually acceptable valuations of any of the Mesolella/Jacobs Properties. Consequently, the independent directors have met and have recommended to the full board of directors of AQSP that all pending purchase and sale offers on the Mesolella/Jacobs Properties be withdrawn.

Note 7 - Subsequent Events

Note 7 - Subsequent Events	9 Months Ended
	Sep. 30, 2015
Notes
Note 7 - Subsequent Events	NOTE 7 – SUBSEQUENT EVENTS We have evaluated subsequent events through the date of filing this quarterly report on Form 10-Q. No events have occurred that would require adjustment to or disclosure in the financial statements.

Note 1 - Basis of Presentatio14

Note 1 - Basis of Presentation and Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2015
Policies
Basis of Presentation	Basis of Presentation – On January 12, 2013, Acquired Sales entered into an agreement with Drumright Group, LLC (“Drumright”) that was closed on February 11, 2013, wherein Acquired Sales sold 100% of the capital stock of Cogility Software Corporation (“Cogility”) to Drumright. Cogility’s results of operations have been reclassified as discontinued operations.
Condensed Financial Statements	Condensed Financial Statements
Use of Estimates	Use of Estimates
Basic and Diluted Earnings (Loss) Per Common Share	Basic and Diluted Earnings (Loss) Per Common Share For the Three Months For the Nine Months Ended Ended September 30, September 30, 2015 2014 2015 2014 Loss from Continuing Operations $(870,495) $(82,963) $(1,137,690) $(214,278) Income (Loss) from Discontinued Operations - 74,605 - 74,605 Net Lncome (Loss) $(870,495) $(8,358) $(1,137,690) $(139,673) Weighted -Average Shares Outstanding 2,269,648 2,269,648 2,269,648 2,269,648 Basic and Diluted Earnings (Loss) per Share Continuing Operations $(0.38) $(0.04) $(0.50) $(0.09) Discontinued Operations - 0.03 - 0.03 Basic and Diluted Earnings (Loss) per Share $(0.38) $(0.01) $(0.50) $(0.06) There were 4,848,774 employee stock options and 938,000 warrants outstanding during the three and nine months ended September 30, 2015 that were excluded from the computation of diluted earnings (loss) per share because their effects would have been anti-dilutive. There were 2,148,774 employee stock options and 938,000 warrants outstanding during the three and nine months ended September 30, 2014 that were excluded from the computation of diluted earnings (loss) per share because their effects would have been anti-dilutive.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In June 2014, the FASB issued ASU No. 2014-12, Compensation-Stock Compensation (Topic 718)-Accounting for Share-Based Payments When the Terms of an Award Provide That a Performance Target Could Be Achieved after the Requisite Service Period (a consensus of the FASB Emerging Issues Task Force). ASU No. 2014-12 requires that a performance target that affects vesting and could be achieved after the requisite service period shall be treated as a performance condition. The effective date will be the first quarter of fiscal year 2016. The Company has not determined the potential effects on the financial statements.

Note 1 - Basis of Presentatio15

Note 1 - Basis of Presentation and Significant Accounting Policies: Basic and Diluted Earnings (Loss) Per Common Share: Schedule of Earnings Per Share, Basic and Diluted (Tables)	9 Months Ended
	Sep. 30, 2015
Tables/Schedules
Schedule of Earnings Per Share, Basic and Diluted	For the Three Months For the Nine Months Ended Ended September 30, September 30, 2015 2014 2015 2014 Loss from Continuing Operations $(870,495) $(82,963) $(1,137,690) $(214,278) Income (Loss) from Discontinued Operations - 74,605 - 74,605 Net Lncome (Loss) $(870,495) $(8,358) $(1,137,690) $(139,673) Weighted -Average Shares Outstanding 2,269,648 2,269,648 2,269,648 2,269,648 Basic and Diluted Earnings (Loss) per Share Continuing Operations $(0.38) $(0.04) $(0.50) $(0.09) Discontinued Operations - 0.03 - 0.03 Basic and Diluted Earnings (Loss) per Share $(0.38) $(0.01) $(0.50) $(0.06)

Note 5 - Shareholders' Equity_

Note 5 - Shareholders' Equity: Schedule of Share-based Compensation, Stock Options and Warrant Activity (Tables)	9 Months Ended
	Sep. 30, 2015
Tables/Schedules
Schedule of Share-based Compensation, Stock Options and Warrant Activity	Weighted-Average Aggregate Weighted-Average Remaining Contractual Intrinsic Shares Exercise Price (a) Term (Years) Value Outstanding, December 31, 2014 6,198,774 $1.56 Terminated warrants (1,350,000) Outstanding, September 30, 2015 4,848,774 $1.56 7.39 $2,125,125 Exercisable, September 30, 2015 3,598,774 $1.46 6.05 $2,125,125 Note: (a)

Note 1 - Basis of Presentatio17

Note 1 - Basis of Presentation and Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2015
Tables/Schedules
Schedule of Earnings Per Share, Basic and Diluted	For the Three Months For the Nine Months Ended Ended September 30, September 30, 2015 2014 2015 2014 Loss from Continuing Operations $(870,495) $(82,963) $(1,137,690) $(214,278) Income (Loss) from Discontinued Operations - 74,605 - 74,605 Net Lncome (Loss) $(870,495) $(8,358) $(1,137,690) $(139,673) Weighted -Average Shares Outstanding 2,269,648 2,269,648 2,269,648 2,269,648 Basic and Diluted Earnings (Loss) per Share Continuing Operations $(0.38) $(0.04) $(0.50) $(0.09) Discontinued Operations - 0.03 - 0.03 Basic and Diluted Earnings (Loss) per Share $(0.38) $(0.01) $(0.50) $(0.06)

Note 5 - Shareholders' Equity (

Note 5 - Shareholders' Equity (Tables)	9 Months Ended
	Sep. 30, 2015
Tables/Schedules
Schedule of Share-based Compensation, Stock Options and Warrant Activity	Weighted-Average Aggregate Weighted-Average Remaining Contractual Intrinsic Shares Exercise Price (a) Term (Years) Value Outstanding, December 31, 2014 6,198,774 $1.56 Terminated warrants (1,350,000) Outstanding, September 30, 2015 4,848,774 $1.56 7.39 $2,125,125 Exercisable, September 30, 2015 3,598,774 $1.46 6.05 $2,125,125 Note: (a)

Note 1 - Basis of Presentatio19

Note 1 - Basis of Presentation and Significant Accounting Policies: Basis of Presentation (Details)	12 Months Ended
	Dec. 31, 2012	Sep. 30, 2013	Jan. 12, 2013
Defense Securities Technology Group
Subsidiary or Equity Method Investee, Cumulative Percentage Ownership after All Transactions	100.00%
Defense & Security Technology Group, Inc
Stock Sold to Acquirer, percent		100.00%
Drumright Group LLC purchase of Cogility
Stock Sold to Acquirer, percent			100.00%

Note 1 - Basis of Presentatio20

Note 1 - Basis of Presentation and Significant Accounting Policies: Basic and Diluted Earnings (Loss) Per Common Share: Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Details
Loss from Continuing Operations	$ (870,495)	$ (82,963)	$ (1,137,690)	$ (214,278)
Income (Loss) from Discontinued Operations	0	74,605	0	74,605
Net Income (Loss)	$ (870,495)	$ (8,358)	$ (1,137,690)	$ (139,673)
Weighted -Average Shares Outstanding	2,269,648	2,269,648	2,269,648	2,269,648
Basic and Diluted Earnings (Loss) per Share
Continuing Operations	$ (0.38)	$ (0.04)	$ (0.50)	$ (0.09)
Discontinued Operations	0	0.03	0	0.03
Basic and Diluted Earnings (Loss) per Share	$ (0.38)	$ (0.01)	$ (0.50)	$ (0.06)

Note 1 - Basis of Presentatio21

Note 1 - Basis of Presentation and Significant Accounting Policies: Basic and Diluted Earnings (Loss) Per Common Share (Details) - shares	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Equity Option
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	4,848,774	2,148,774
Warrant
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	938,000	938,000

Note 2 - Risks and Uncertaint22

Note 2 - Risks and Uncertainties (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Accumulated deficit	$ (13,485,118)		$ (13,485,118)		$ (12,347,428)
Loss from Continuing Operations	(870,495)	$ (82,963)	(1,137,690)	$ (214,278)
Net cash used in operating activities of continuing operations			(368,265)	$ (201,312)
Bad debt expense	$ 835,277		835,277
Secured Promissory Note
Bad debt expense			737,850
Interest receivable
Bad debt expense			$ 97,427

Note 3 - The William Noyes We23

Note 3 - The William Noyes Webster Foundation, Inc. (Details) - USD ($)	1 Months Ended	3 Months Ended	7 Months Ended	9 Months Ended
	Jul. 31, 2014	Sep. 30, 2015	Jul. 31, 2015	Sep. 30, 2015	Sep. 30, 2014
Note receivable payment				$ 135,350	$ 602,500
Bad debt expense		$ 835,277		835,277
Secured Promissory Note
Note receivable payment	$ 602,500
Bad debt expense				737,850
Secured Promissory Note | William Noyes Webster Foundation Inc
Debt Instrument, Face Amount		$ 1,500,000		$ 1,500,000
Note receivable payment	600,000		$ 135,350
Note Receivable			$ 737,850
Debt Instrument, Interest Rate, Stated Percentage		12.50%		12.50%
Secured Promissory Note | William Noyes Webster Foundation Inc | Payment To Consultant
Note receivable payment	$ 2,500
Secured Promissory Note | William Noyes Webster Foundation Inc | Unfunded Portion of Note
Debt Instrument, Face Amount		$ 897,500		$ 897,500
Interest receivable
Bad debt expense				$ 97,427

Note 4 - Notes Payable (Details

Note 4 - Notes Payable (Details)	Jul. 14, 2014USD ($)
Roberti Jacobs Family Trust
Debt Instrument, Face Amount	$ 300,000

Note 5 - Shareholders' Equity25

Note 5 - Shareholders' Equity: Schedule of Share-based Compensation, Stock Options and Warrant Activity (Details)	9 Months Ended
	Sep. 30, 2015USD ($)$ / sharesshares
Options, Outstanding, Beginning Balance	6,198,774
Options, Outstanding, Weighted Average Exercise Price, Beginning Balance | $ / shares	$ 1.56
Options, Outstanding, Ending Balance	4,848,774
Options, Outstanding, Weighted Average Exercise Price, Ending Balance | $ / shares	$ 1.56
Options, Outstanding, Weighted Average Remaining Term	7 years 4 months 20 days
Options, Outstanding, Intrinsic Value | $	$ 2,125,125
Options, Exercisable	3,598,774
Options, Exercisable, Weighted Average Exercise Price | $ / shares	$ 1.46
Options, Exercisable, Weighted Average Remaining Term	6 years 18 days
Options, Exercisable, Intrinsic Value | $	$ 2,125,125
Warrant
Terminated Warrants	(1,350,000)

Note 5 - Shareholders' Equity26

Note 5 - Shareholders' Equity (Details) - USD ($)	3 Months Ended	9 Months Ended		12 Months Ended
	Mar. 31, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2013	Feb. 28, 2014
Class of Warrant, Outstanding		938,000
Payment to Mr. Ghourdjian for Purchase of Common Stock	$ 20,000		$ 20,000	$ 30,000
Matthew Ghourdjian
Share Price					$ 0.07
Common Stock
Stock Repurchased During Period, Shares				690,796
Warrant | Notes Payable to Related Parties
Weighted Average Exercise Price		$ 2.32
Weighted Average Remaining Contractual Term		1 year 1 month 10 days
Aggregate Intrinsic Value		$ 0

Note 6 - Contingent Contractu27

Note 6 - Contingent Contractual Obligations and Commercial Commitments (Details)	9 Months Ended
	Sep. 30, 2015USD ($)
MVJ Realty, LLC
Debt Instrument, Face Amount	$ 23,000
Debt Instrument, Use of proceeds	$23,000 was used as follows: (a) $9,500 was used by the Foundation to pay the rent of the Plymouth Cultivation Facility for the month of May, 2015; (b) $6,900 was used by the Foundation to pay the rent of the Dennis Dispensary for the months of April and May, 2015; (c) $3,600 was used by the Foundation to pay for the general liability insurance policy covering the Plymouth Cultivation Facility and the Dennis Dispensary; and (d) $3,000 was used by the Foundation to pay the application fees for two applications (the “Two New Applications”) by the Foundation to the Commonwealth of Massachusetts for licenses (the “Two New Licenses”) to operate two new medical marijuana dispensaries in Massachusetts (the “Two New Dispensaries”).
Debt Instrument, Repurchase Amount	$ 23,000
Parere Partners Inc. | Medical marijuana on Cape Cod
Commitments Under Agreements with the William Noyes Webster Foundation, Inc.	(i) 5% of the first $1,000,000 of the aggregate principal amount of such loans, (ii) 4% of the second $1,000,000 of the aggregate principal amount of such loans, (iii) 3% of the third $1,000,000 of the aggregate principal amount of such loans, (iv) 2% of the fourth $1,000,000 of the aggregate principal amount of such loans, and (v) 1% of the aggregate principal amount of such loans that are in excess of $4,000,000. As of September 30, 2015, no finder’s fees are due to Parare Partners, Inc.
William Noyes Webster Foundation Inc | Secured Promissory Note
Debt Instrument, Face Amount	$ 1,500,000
William Noyes Webster Foundation Inc | MVJ Realty, LLC | Secured Promissory Note
Debt Instrument, Increase	$ 23,000